Fengzhen Mo
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 15
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 2
- Oncology 10
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Xiaoling Lü (21 shared papers)Xiaoqiong Hou (15 shared papers)Zhuoran Tang (10 shared papers)Xiaomei Yang (16 shared papers)Aiqun Liu (14 shared papers)Siliang Duan (8 shared papers)Shihua Yin (8 shared papers)Zixi Hu (6 shared papers)
- Journals
- Journal of Biomedical Nanotechnology (5 papers)Theranostics (4 papers)International Journal of Nanomedicine (3 papers)Journal of Nanoscience and Nanotechnology (2 papers)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fengzhen Mo
22 papers receiving 522 citations
Peers
Comparison fields: 5 of 57
- Immunology 211
- Oncology 213
- Radiology, Nuclear Medicine and Imaging 122
- Biomaterials 53
- Molecular Biology 222
Countries citing papers authored by Fengzhen Mo
This map shows the geographic impact of Fengzhen Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengzhen Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengzhen Mo more than expected).
Fields of papers citing papers by Fengzhen Mo
This network shows the impact of papers produced by Fengzhen Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengzhen Mo. The network helps show where Fengzhen Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengzhen Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 84 | |
| 2 | 2021 | 58 | |
| 3 | 2018 | 39 | |
| 4 | 2020 | 37 | |
| 5 | 2021 | 33 | |
| 6 | 2018 | 32 | |
| 7 | 2017 | 32 | |
| 8 | 2019 | 31 | |
| 9 | 2019 | 23 | |
| 10 | 2023 | 17 | |
| 11 | 2023 | 17 | |
| 12 | 2019 | 16 | |
| 13 | 2019 | 16 | |
| 14 | 2018 | 16 | |
| 15 | 2024 | 15 | |
| 16 | 2019 | 15 | |
| 17 | 2020 | 14 | |
| 18 | 2021 | 13 | |
| 19 | 2019 | 7 | |
| 20 | 2025 | 5 |
About Fengzhen Mo
Fengzhen Mo is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, having authored 22 papers that have together received 523 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nanowire Synthesis and Applications (2 papers), Glycosylation and Glycoproteins Research (2 papers), RNA Interference and Gene Delivery (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Immunology (211 citations), Oncology (213 citations), Radiology, Nuclear Medicine and Imaging (122 citations), Biomaterials (53 citations) and Molecular Biology (222 citations). Fengzhen Mo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoling Lü, Xiaoqiong Hou, Zhuoran Tang, Xiaomei Yang, Aiqun Liu, Siliang Duan, Shihua Yin, Zixi Hu, Xiaomei Yang and Shenxia Xie. Their work appears in journals such as Journal of Biomedical Nanotechnology, Theranostics, International Journal of Nanomedicine, Journal of Nanoscience and Nanotechnology and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.